Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cochlear Limited ( (AU:COH) ) has issued an update.
Cochlear Limited reported a positive half-yearly financial performance as of December 31, 2024, with a 5% increase in sales revenue and a 7% rise in total revenue, reaching $1,171.8 million. The company’s net profit attributable to members grew by 7% to $205.1 million, and the interim dividend per share was raised by 8% to $2.15. These results reflect Cochlear’s strong market presence and robust operational performance, potentially enhancing investor confidence and solidifying its position in the medical device industry.
More about Cochlear Limited
Cochlear Limited operates in the medical device industry, focusing primarily on implantable hearing solutions. The company is renowned for its cochlear implants and related products, which aim to improve hearing for individuals with severe to profound hearing loss.
YTD Price Performance: 5.53%
Average Trading Volume: 86
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $12.6B
For detailed information about COH stock, go to TipRanks’ Stock Analysis page.
